Visalytics
Visalytics
dismissed EB-2 (NIW)

Associate Director, Master Data Management ["MDM"] Implementation Lead

Pharmaceutical Company · India · 2024-11-18

Decision Date
2024-11-18
This case is from a USCIS Administrative Appeals Office (AAO) appeal decision. Appeal cases represent a subset of petitions and may not reflect typical outcomes.

Proposed Endeavor

The Beneficiary proposes to continue working as an Associate Director, Master Data Management (MDM) Implementation Lead for a pharmaceutical company. His endeavor involves developing, implementing, and managing digital platforms using AI and machine learning to optimize laboratory workflows, integrate clinical trial data, ensure data security, improve access to high-quality information, and accelerate drug research, development, and regulatory approval processes.

Framework Evaluation

0 of 3 criteria met
1 The proposed endeavor has both substantial merit and national importance. Not Met

USCIS found that while the proposed endeavor had substantial merit, the evidence did not demonstrate national importance, as its impact was not shown to extend beyond the employer and its direct business interests.

Why This Petition Was Denied

The appeal was dismissed because the Petitioner failed to satisfy Dhanasar's first prong, specifically the 'national importance' criterion. While the Beneficiary's academic credentials (Bachelor of Technology in Computer Engineering from India) and experience as a data engineer and MDM specialist were acknowledged, the evidence did not demonstrate that his specific endeavor would have a significant potential to employ U.S. workers, substantial positive economic impact, or a broader national or global impact beyond his employer and its direct partners. The decision emphasized that the importance of the industry or the Beneficiary's profession does not equate to the national importance of his specific proposed endeavor.

Evidence

Evidence Types
Reference Letters Dependent
Original Contributions

Similar Cases

Others

Pharmaceuticals

USCIS EB-2 (NIW) dismissed
2024-10-21
The Beneficiary proposes to streamline and ensure the quality of pharmaceutical research, development, and regulatory approval processes through the development, enhancement, and maintenance of cloud, DevOps, and database systems. This involves enhancing clinical data management systems to automate drug development, protect sensitive patient data, and integrate cloud and AI automation technologies to optimize the process.

Chief Executive Officer (CEO)

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
Florida 2024-04-19
The petitioner proposes to launch and develop a Florida-based company focused on a digital learning and instruction platform for pharmaceutical sales professionals. The endeavor involves coaching sales teams and developing commercial chains for American products, specifically in ophthalmology-related pharmaceuticals, to help U.S. companies reach international markets.

Chemist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
New Jersey 47 days 2025-07-30
The petitioner proposes to apply pharmaceutical science methodologies to streamline drug development and ensure regulatory compliance. Her work focuses on formulation development, analytical validation, and regulatory strategy improvement to reduce the time and cost of bringing drug compounds from the lab to the market.
View Case

Pharmacist

Pharmaceuticals

USCIS EB-2 (NIW) rfe dismissed
Florida 2025-03-31
The petitioner proposes to operate a comprehensive pharmaceutical service providing online health services and pharmaceuticals to patients across the country. The endeavor focuses on healthcare outcomes for vulnerable populations, such as the elderly and those with chronic conditions, through medication dispensing and patient education.

Frequently Asked Questions

A dismissed EB-2 NIW petition means USCIS found the evidence insufficient to meet the eligibility criteria. Common reasons include weak documentation, failure to meet the required number of criteria, or insufficient evidence of the claimed qualifications. Petitioners can refile with stronger evidence or explore alternative visa categories.

Browse More Cases

More dismissed cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-11-18.

Browse all cases

At a Glance

Outcome dismissed
Criteria Met 0 / 3
Evidence Types 2

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist